ask="3.19"
ask_size="300"
average_daily_volume="10300"
bid="N/A"
bid_size="N/A"
book_value="2.61"
change="-0.01"
change_from_200_day_moving_average="-1.10"
change_from_50_day_moving_average="-0.53"
change_from_52_week_high="-2.55"
change_From_52_week_low="0.54"
change_in_percent="-0.32%"
close="3.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.77"
ebitda="-19.70M"
eps_estimate_current_year="-1.65"
eps_estimate_next_quarter="-0.44"
eps_estimate_next_year="-1.70"
ex_dividend_date="N/A"
float_shares="1878000"
high="3.19"
high_52_weeks="5.70"
last_trade_date="2/1/2017"
last_trade_price="3.15"
last_trade_size="100"
last_trade_time="3:54pm"
low="3.10"
low_52_weeks="2.61"
market_capitalization="36.94M"
moving_average_200_day="4.25"
moving_average_50_day="3.68"
name="Nexvet Biopharma plc"
notes="N/A"
one_year_target_price="8.00"
open="3.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-25.88%"
percent_change_from_50_day_moving_average="-14.33%"
percent_change_from_52_week_high="-44.74%"
percent_change_from_52_week_low="+20.69%"
previous_close="3.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.21"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11726000"
short_ratio="10.78"
stock_exchange="NGM"
symbol="NVET"
volume="2003"
weeks_range_52="2.61 - 5.70"
